baber/WOPTO huggingface dataset:
Patent NZ-566397-A (NZ)
Title: Crystalline forms of the di-sodium salt of 5-CNAC
Inventor: DHOOT NIKHIL
IPC: C07C235/32
Filed: 2006-09-18
Abstract: Disclosed is a crystalline form of the disodium salt of N-(5-chlorosalicyloyl)-8- aminocaprylic acid selected from: (a) a first crystalline monohydrate of the disodium salt of N-(5-chlorosalicyloyl)- 8-aminocaprylic acid exhibiting an X-ray powder diffraction pattern having at least one peak in degrees 2 theta plus or minus 0.2 degrees 2 theta selected from 7.5, 10.4, 14.2, 15.0, 15.5, 16.1, 18.04, 20.8, 23.6, 24.1,24.5, 24.8, 25.4, 26.6, 27.2, 27.5, 29.6 and 31.5; (b) a crystalline ethanol solvate of the disodium salt of N-(5-chlorosalicyloyl)-8- aminocaprylic acid exhibiting an X-ray powder diffraction pattern having at least one peak in degrees 2 theta plus or minus 0.2 degrees 2 theta selected from 7.5, 14.1, 16.5, 18.5,25, and 26; (c) an octahydrate of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid; (d) a second crystalline monohydrate of the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid exhibiting an X-ray powder diffraction pattern having at least one peak in degrees 2 theta plus or minus 0.2 degrees 2 theta selected from 7.2, 18.2, and 24.7.
Patent NZ-569705-A (NZ)
Title: Process for manufacturing particles based on natural calcium carbonate and salts of acrylic acid-ethylene, suspensions and dry pigments obtained, and uses thereof
Inventor: BURI MATTHIAS
IPC: C08K3/00
Filed: 2007-01-09
Abstract: Disclosed is a process of preparation of at least one mineral matter and/or at least one pigment, including a natural and/or precipitated calcium carbonate, made at once partially organophilic and partially hydrophilic, and including the stages of: (a) supplying at least one mineral matter and/or one pigment including natural and/or precipitated calcium carbonate, in a dry form or in the form of an aqueous dispersion and/or suspension, (b) possibly dry grinding and/or grinding in an aqueous medium the mineral matter and/or the pigment resulting from stage (a),(c) treating the mineral matter and/or the pigment resulting from stage a) and/or from stage (b)(d) possibly drying the mineral matter and/or the pigment resulting from stage (a) and/or (b) and/or (c), wherein:- treatment stage (c) corresponds to a stage of blending in an aqueous medium and/or of grinding in an aqueous medium, and/or of concentration in an aqueous medium, of the mineral matter and/or the pigment obtained from stage (a) and/or from stage (b), in the presence of at least one salt of ethylene acrylic acid (such as a sodium or magnesium salt of ethylene-acrylic acid copolymer), - a dispersing agent and/or grinding aid agent is introduced before and/or during the treatment stage (c). The disclosure also relates to aqueous dispersions and dry pigments made by said process and the use of these aqueous dispersions and dry pigments in the field of plastics, paints and paper.
Patent NZ-570877-A (NZ)
Title: A container body with a one time attached upper skirt that forms storage for a spray wand handle
Inventor: ARCURI JOSEPH F
IPC: B65D25/48
Filed: 2007-01-30
Abstract: A fluid dispensing system including a pump assembly for pressurizing a low cost container is disclosed. The container (20) is non-reversibly connected to a coupler module (100). This allows for different manufacturing processes to be used for the various parts, the container (20) being blow moulded for low cost and the coupler (100) injection moulded for narrow dimensional tolerance. A grip body (82) of a wand assembly (80) is releasably connected to the coupler module (100), this being achieved accurately but injection moulding the grip body (82) as well as the coupler module (100). A discharge conduit (66) fluidly connects the wand assembly (80) to the container (20). The grip body (82) is slideable relative to a rigid conduit (68) between a retracted storage position and an extended operable position. A bleed valve and pump assembly (40) is also disclosed.
Patent NZ-574811-A (NZ)
Title: Polymeric low-tack acrylic ophthalmic and otorhinolaryngological device materials suited for use as intraocular lens materials
Inventor: KARAKELLE MUTLU
IPC: A61F2/16
Filed: 2007-07-20
Abstract: Disclosed is a polymeric low-tack acrylic opthalamic and otorhinolaryngological device material comprising: 1. a principle device forming monomer which is an aryl acrylic hydrophobic monomer of formula (I); 2. a methacrylate-terminated polystyrene macromer of formula (II); 3. and a cross linking monomer, wherein all substituents are as defined in the specification. Also defined is a device comprising the device material wherein the device is selected from the group consisting of a contact lens; a keratoprostheis, a corneal inlay or ring; an otological ventilation tube; and a nasal implant.
Patent NZ-583119-A (NZ)
Title: An adaptor connecting between a roller assembly and a support assembly from two dissimilar blind systems
Inventor: LICCIARDI DI STEFANO CARMELO JOSEPH
IPC: F16D1/06
Filed: 2010-02-05
Abstract: An adapter (100) for enabling components of a blind system to connect to different types of support structures is disclosed. The adapter (100) includes a body having a first coupling portion (108a) and a second coupling portion (118). The first coupling portion (108a) is adapted to connect to a corresponding coupling portion of a blind component, the blind component being fitted to a rotatable roller for extending or retracting a screen. The second coupling portion (118) is adapted to connect to a corresponding coupling portion of a fixed support structure. When the adapter (100) is fitted to the blind component, the first coupling portion (108a) forms an interlocking engagement with the coupling portion of the blind component to resist detachment from, and rotation relative to, each other.
Patent NZ-585032-A (NZ)
Title: Method of producing acid stable protein products and products so produced
Inventor: NAIR LALITHA
IPC: A23C9/154
Filed: 2008-08-28
Abstract: Disclosed is a method of producing an acidified protein component, comprising the steps of: providing a stabilised acid component comprising an acid and an amount of a first stabiliser formulation in the form of an anionic hydrocolloid polysaccharide stabilizer gum, dissolved in water, the amount of the first stabiliser formulation being sufficient to prevent the occurrence of any unbound hydrogen ions in the stabilised acid component; providing a protein component in the form of an undenatured liquid or powder protein in micellar form and mixing the protein component with a second stabiliser formulation in the form of an anionic hydrocolloid polysaccharide stabilizer gum, dissolved in water to produce a stabilized protein component comprising stabilized protein micelles; and blending the stabilised acid component with the protein component to form the acidified protein component wherein the protein in the protein component maintains its negative charge and its micellar form after the stabilised acid component is blended with the stabilized protein component.
Patent NZ-586589-A (NZ)
Title: Novel insulin analogues having an extremely delayed time-action profile
Inventor: HABERMANN PAUL
IPC: C07K14/62
Filed: 2009-01-06
Abstract: Disclosed is insulin analogs having a basal time-action profile, which are characterized by the addition and/or substitution of negatively and positively charged amino acid residues and by an amidation of the C-terminal carboxy group of the B chain and histidine in position 8 of the insulin A chain. The invention also relates to the production and use thereof.
Patent NZ-588635-A (NZ)
Title: Aminopyridine derivatives as inhibitors of tissue kallikrein (KLK1), useful for treating inflammatory diseases
Inventor: EVANS DAVID MICHAEL
IPC: C07D409/12
Filed: 2009-04-28
Abstract: Provided is a kallikrein inhibitor which is an aminopyridine derivative of Formula (I), with defined substituents. The compound can be used to treat various allergic and inflammatory conditions including asthma, cough, arthritis, psoriasis among others.
Patent NZ-592369-A (NZ)
Title: Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment
Inventor: SUN HAIJUN
IPC: C07K16/28
Filed: 2009-10-15
Abstract: 592369 Provided is an antibody that specifically binds to human FGFR-3, comprising a CDRH1 having the sequence GYMFTSYGIS, a CDRH2 having the sequence WVSTYNGDTNYAQKFQG, a CDRH3 having the sequence VLGYYDSIDGYYYGMDV, a CDRL1 having the sequence GGNNIGDKSVH, a CDRL2 having the sequence LDTERPS, and a CDRL3 having the sequence QVWDSGSDHVV. The antibody is useful for treating cancer.
Patent NZ-595298-A (NZ)
Title: An automated milking parlour with robotic station for operating multiple milking stations
Inventor: KEIJSER BERGOO MALIN
IPC: A01K1/12
Filed: 2010-04-14
Abstract: 595298 Disclosed is a rotary cow milking parlour (1) requiring reduced operator intervention and improved efficiencies. The milking parlour comprises at least first and second robotic manipulation devices (100, 200) and a plurality of milking stalls (5) provided on a platform (3) moveable relative to the robotic manipulation devices. The at least first and second robotic manipulation devices are so positioned as to be capable of simultaneously servicing neighbouring milking stalls on the platform. Each one of the at least first and second robotic manipulation devices is operable to attach, to the same animal in a milking stall, a subset of a total required number of teat cups to be attached to the teats of said animal in the milking stall, such that any particular animal has teat cups attached to its teats by at least two robotic manipulation devices. Where four robotic manipulation devices are provided, each one is operable to attach successively one teat cup to a teat of an animal in a milking stall as said stall moves past each robotic manipulation device upon movement of said platform. The arm of each robotic manipulation device is sufficiently extendable to provide each robotic manipulation device with a working range spanning the width of at least two stalls.
Patent NZ-597004-A (NZ)
Title: Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
Inventor: HAENSLER JEAN
IPC: A61P31/04
Filed: 2010-05-12
Abstract: 597004 Provided is a method for adjuvanting lipopolysaccharide (LPS) from a Gram-negative bacterium, according to which: (i) LPS or LPS liposomes (LPS formulated in liposomes) is (are) mixed with the lipidated human transferring receptor subunit B (lipidated TbpB) from, Neisseria meningitidis or a lipidated fragment thereof; or (ii) LPS and the lipidated TbpB from N meningitidis or a lipidated fragment thereof are formulated together in liposomes; or (iii) LPS is conjugated with the lipidated TbpB from N meningitidis or a lipidated fragment thereof; in order to obtain a preparation which does not contain OMVs and which is capable of inducing, after administration to a mammal, an anti-LPS immune response which is improved by comparison with the anti-LPS immune response observed after administration of the corresponding preparation in which the lipidated TbpB from N meningitidis or a lipidated fragment thereof is omitted.
Patent NZ-599132-A (NZ)
Title: Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
Inventor: COOK BRIAN NICHOLAS
IPC: A61K31/437
Filed: 2010-10-19
Abstract: 599132 Diclosed are indazole and pyrazolopyridine CCR1 receptor antagonists of the formula (I), wherein X is nitrogen or, C-R2; Ar1 is carbocycle, heteroaryl or heterocyclyl each optionally substituted by one to three Ra; Ar2 is carbocycle, heteroaryl or heterocyclyl, each optionally substituted by one to three Rb; Cyclic G is carbocycle, or heterocyclyl each optionally substituted by one to two R8; R1 is hydrogen, C1-6 alkyl or C1-6 alkoxy C1-6 alkyl. Also disclosed are compositions, methods of making and using compounds of the formula (I). compounds of the disclosure include: 1-(4-Fluoro-phenyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxylic acid (1-1,3,4-thiadiazol-2-yl-cyclopropyl)-amide, 1-(4-Fluoro-phenyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxylic acid [1-(5-bromo-pyrimidin-2-yl)-cyclopropyl]-amide, 1-(4-Fluoro-phenyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxylic acid [1-(5-methanesulfonyl-pyrimidin-2-yl)-cyc1opropyl]-amide, 4-(1-{ [1-(4-Fluoro-phenyl)-1H-pyrazolo[3,4-c]pyridine-4-carbonyl]-amino} -cyclopropyl)-benzoic acid, And 6-Cyano-1-(4-fluoro-phenyl)-1H-indazole-4-carboxylic acid [1-(2-methanesulfonyl-pyridin-4-yl)-cyclopropyl]-amide
Patent NZ-600494-A (NZ)
Title: Magazine unit for strips of fixing means
Inventor: KUCHLER GERHARD
IPC: B25C1/00
Filed: 2010-12-27
Abstract: 600494 A magazine unit is disclosed for supplying strips (1) of fixing means such as nails to a driving assembly. The strips (1) are stacked one on top of another in a magazine shaft (9) with a fixing-means support (10) underneath for feeding the strips (1) along their longitudinal axis (11) to the driving assembly. A separating unit (12) is arranged in the lower region of the magazine shaft (9) to release the strips (1) individually to the fixing-means support (10). The separating unit (12) is or can be coupled mechanically to a feed slide (13) so that operation of the feed slide (13) triggers the strip (1) located in the lowest magazine position to be released to the fixing-means support (10).
Patent NZ-614658-A (NZ)
Title: Antibody fc variants
Inventor: MOESSNER EKKEHARD
IPC: C07K16/28
Filed: 2012-03-27
Abstract: Discloses a polypeptide comprising an Fc variant of a wild-type human IgG Fc region, said Fc variant comprising an amino acid substitution at position Pro329, wherein Pro329 of a wild-type human Fc region is substituted with glycine or arginine, and wherein the Fc variant comprises at least two further amino acid substitutions, wherein said further amino acid substitutions are L234A and L235A of the human IgG1 Fc region or S228P and L235E of the human IgG4 Fc region, wherein the residues are numbered according to the EU index of Kabat, and wherein said polypeptide exhibits an at least 10-fold reduced affinity to the human FcγRIIIA and a reduced affinity to the human, FcγRIIA, FcγRI and the human C1q receptor, compared to a polypeptide comprising the wildtype IgG Fc region, and wherein the ADCC induced by said polypeptide is reduced to 0-20% of the ADCC induced by the polypeptide comprising a wild-type human IgG Fc region. Also discloses use of the Fc region for down-modulation of ADCC or ADCP.
Patent NZ-616411-A (NZ)
Title: Actuation and valve mechanism
Inventor: AUGHTON DAVID JOHN
IPC: F16L55/10
Filed: 2012-03-30
Abstract: Disclosed are a fluid control barrier and a cable drive device for the barrier. The fluid control barrier acts as a valve within, or at the end of, a pipe (74). The barrier comprises a bi-foldable barrier member having a pair of plates (82, 84) with a hinge (86) along their straight edges. The hinge may be pinned to the pipe allowing the plates to rotate with respect to the pipe, allowing for opening and closing of the fluid control barrier. Actuating means (98, 100) are attached to the plates to allow said bi-foldable barrier member to be opened and closed. The actuating means are driven by a cable drive device (120). The frame within the pipe also includes a sealing lip or flange (152) for air-tight or water-tight sealing of the fluid in the pipe. The barrier is also suitable for external attachment to the pipe.
Patent NZ-625857-A (NZ)
Title: Protective cases and methods of making
Inventor: WYNER DANIEL M
IPC: H05K5/02
Filed: 2012-11-09
Abstract: Disclosed is a protective case (10) for a media device with a built-in camera lens. The protective case (10) comprises a protective element (200), a housing element and a lens window. The protective element (200) comprises a protective element base and a protective element sidewall extending upwardly from the protective element base to define a protective element enclosure adapted to receive the media device. The protective element (200) comprises a resilient material. The housing element comprises a housing element base (22) and a housing element sidewall (20) extending upwardly from the base (22) to define a housing element enclosure adapted to receive the protective element (200), and a cover (30) removably connected to the base (22). The lens window (50) disposed in the housing element base (22). When the media device is disposed in the protective case (10), the built-in camera lens is coaxially aligned with the lens window (50), and the protective element (200) is sufficiently compressed against the interior of the housing element enclosure to maintain the built-in lens in coaxial alignment with the lens window (50).
Patent NZ-703775-A (NZ)
Title: A counterbalancing system for backpacks with a novel attachment system
Inventor: AARN TATE
IPC: A45F3/14
Filed: 2014-01-07
Abstract: A Bag with one or more pockets which attach to the shoulder straps and hip belt of a backpack in front of the wearer. The top rear of the Bag attaches to the chest strap of the backpack via a pair of straps and buckles which exit from the top rear edge of the Bag in a V orientation. The centre bottom rear of the Bag has a downward projecting flat flange and horizontal gusset connecting the top of the flange with the rear of the Bag. The flange slips over the centre buckle of the backpack’s hip belt to secure the bottom of the Bag to the wearer and the horizontal flange transfers the load in the Bag onto the hip belt. When the top buckles of the Bag are different to the buckles of the backpack chest strap, the adjustable male buckle of the backpack chest strap is swapped for the adjustable male buckle on the Bag such that the buckles on one side, comprised of the male and female portions from the backpack and the buckles on the other side compose the male and female portions from the Bag. In this way, the buckles on the each side become compatible. Once the buckles are set up to be compatible, this simplicity of slipping the bottom flange of the Bag over the hip belt and clipping the top buckles from the bag to the chest strap buckles of the backpack allows even a child to readily master such a system. When the top buckles of the Bag are different to the buckles of the backpack chest strap, the adjustable male buckle of the backpack chest strap is swapped for the adjustable male buckle on the Bag. In this way, the buckles on the left side become compatible and the buckles on the right side become compatible.
Patent NZ-704958-A (NZ)
Title: Improved compositions of substantially spherical urea formaldehyde polymer particles
Inventor: GABRIELSON KURT D
IPC: C05G3/90
Filed: 2013-08-15
Abstract: An additive composition for a fertiliser composition, the additive composition comprising: a granular solid composition comprising: a) from about 30 % to about 70% of an active agent, wherein the active agent is N-(n-butyl)thiophosphoric triamide (NBPT); and b) from about 70 % to about 30 % by weight of substantially spherical urea-formaldehyde polymer (UFP) particles based on the total weight of the granular solid composition, wherein the active agent is substantially adhered to the UFP particle. The formulation can be used to improve the flow of the fertiliser composition.
Patent NZ-705499-A (NZ)
Title: Compositions comprising peg and ascorbate
Inventor: UNGAR ALEX
IPC: A61P1/10
Filed: 2013-09-10
Abstract: The present invention relates to a method of cleansing the colon using colon cleansing solutions, and compositions and kits associated therewith. The invention provides a colon cleansing solution comprising: a) 300 to 800 mmol per litre ascorbate anion provided by a mixture of (i) ascorbic acid and (ii) one or more salts of ascorbic acid; the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per litre polyethylene glycol. The solution of the invention has a palatable taste. The particular ratio of ascorbic acid to salt of ascorbic acid enables the salty taste of ascorbate salt to be balanced by sourness from acid to a palatable extent, whilst at the same time not reducing the osmotic effect of the ascorbate component or making the solution too sour. The solution is highly effective as a colon cleansing solution when ingested in a lower volume than many prior art solutions, and it has a good tolerability profile. The invention also or alternatively provides non-therapeutic methods of cleaning the colon, use in the manufacture of a medicament for the treatment of constipation or faecal impaction, kits associated with, or making use of the solutions, and/or compositions for the preparation of the solutions.
Patent NZ-706826-A (NZ)
Title: Rotary head data storage and retrieval system and method with tape medium having transverse primary data tracks and longitudinal secondary data track
Inventor: MADISON CARL
IPC: G11B27/28
Filed: 2013-11-06
Abstract: Disclosed is a data storage and retrieval system including a head carriage unit having multiple heads disposed at a working surface and a tape drive unit configured to move the tape past the working surface in a direction substantially parallel to a tape length. The heads are configured to write or read primary data tracks on the tape as the head carriage unit rotates and the tape moves past the working surface. The primary data tracks have an accurate shape and extend substantially along a tape width. The heads are also configured to write or read a secondary data track on the tape as the head carriage unit rotates and the tape moves past the working surface. The secondary data track extends substantially along the tape length along one or both edges of the tape. Using the secondary data track, the search and seek operations can be performed at higher linear tape speeds than using the primary data tracks.
Patent NZ-715073-A (NZ)
Title: Nasal assembly
Inventor: GUNEY MEMDUH
IPC: A61M16/06
Filed: 2004-02-20
Abstract: A nasal assembly (10) for delivering breathable gas to a patient includes a frame (16) having an integrally formed first connector portion (24). A nozzle assembly (18) includes a gusset or base portion (48) and a pair of nozzles (50). At least one inlet conduit is structured to deliver breathable gas into the frame and nozzle assembly for breathing by the patient. A pair of second connector portions (26) are removably and rotatably connected to respective first connector portions of the frame and are in communication with respective inlet conduits, e.g., directly or via angle connectors. A headgear assembly (20) is removably connected to the pair of second connector portions and/or the angle connectors so as to maintain the frame and the nozzle assembly in a desired adjusted position on the patient’s face.